Vaccine composition
AssigneeAventis Pasteur Limited
InventorJean Haensler
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical composition comprising at least one vaccine antigen, which also comprises at least one phosphoric ester derivative of phosphatidylcholine having the structure: in which: R1 is a lower alkyl, R2 and R3 are identical or different, and can each represent linear hydrocarbon-based chains having from 13 to 21 carbon atoms.
Claims14
A pharmaceutical composition comprising at least one vaccine antigen-, and at least one phosphoric ester derivative of phosphatidylcholine having the structure:
- in which:
- R1 is a lower alkyl,
- R2 and R3 are identical or different, and can each represent linear hydrocarbon-based chains having from 13 to 21 carbon atoms.
6-9. (canceled)
A method for immunizing a mammal, according to which at least one vaccine antigen is administered to said mammal and also administered to said mammal is a phosphoric ester derivative of phosphatidylcholine having the structure:
- in which:
- R1 is a lower alkyl, R2 and R3 are identical or different, and can each represent linear hydrocarbon-based chains having from 13 to 21 carbon atoms.
Dependencies are inferred from the claim text.